Puriblood Medical Co., Ltd. (6847.TWO)

TWD 78.4

(-1.51%)

Revenue Summary of Puriblood Medical Co., Ltd.

  • Puriblood Medical Co., Ltd.'s latest annual revenue in 2023 was 125.26 Million TWD , down -8.86% from previous year.
  • Puriblood Medical Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 16.78 Million TWD , down 0.0% from previous quarter.
  • Puriblood Medical Co., Ltd. reported a annual revenue of 137.44 Million TWD in annual revenue 2022, up 151.79% from previous year.
  • Puriblood Medical Co., Ltd. reported a annual revenue of 54.58 Million TWD in annual revenue 2021, up 41.25% from previous year.
  • Puriblood Medical Co., Ltd. reported a quarterly revenue of 16.78 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Puriblood Medical Co., Ltd. reported a quarterly revenue of 16.14 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Puriblood Medical Co., Ltd. (2023 - 2019)

Historical Annual Revenue of Puriblood Medical Co., Ltd. (2023 - 2019)

Year Revenue Revenue Growth
2023 125.26 Million TWD -8.86%
2022 137.44 Million TWD 151.79%
2021 54.58 Million TWD 41.25%
2020 38.64 Million TWD 1149.06%
2019 3.09 Million TWD 0.0%

Peer Revenue Comparison of Puriblood Medical Co., Ltd.

Name Revenue Revenue Difference
BIONET Corp. 1.12 Billion TWD 88.888%
DIVA Laboratories, Ltd. 893.84 Million TWD 85.985%
Genetics Generation Advancement Corp. 592.5 Million TWD 78.858%
Welgene Biotech Co.,Ltd. 280.54 Million TWD 55.349%
TFBS Bioscience Inc. 231.91 Million TWD 45.986%